According to Kilroy Realty's latest financial reports the company's total debt is $5.05 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $5.05 B | 15.15% |
2022-12-31 | $4.38 B | 4.62% |
2021-12-31 | $4.19 B | 4.3% |
2020-12-31 | $4.02 B | 10.14% |
2019-12-31 | $3.65 B | 24.5% |
2018-12-31 | $2.93 B | 24.95% |
2017-12-31 | $2.34 B | 1.16% |
2016-12-31 | $2.32 B | 4.25% |
2015-12-31 | $2.22 B | -9.88% |
2014-12-31 | $2.46 B | 11.99% |
2013-12-31 | $2.20 B | 8.04% |
2012-12-31 | $2.04 B | 12.06% |
2011-12-31 | $1.82 B | 26.07% |
2010-12-31 | $1.44 B | 48.5% |
2009-12-31 | $0.97 B | 25.77% |
2008-12-31 | $0.77 B | -9.22% |
2007-12-31 | $0.85 B | -3.09% |
2006-12-31 | $0.87 B | 4.38% |
2005-12-31 | $0.84 B | 5.1% |
2004-12-31 | $0.80 B | 5.31% |
2003-12-31 | $0.76 B | -0.13% |
2002-12-31 | $0.76 B | 6.64% |
2001-12-31 | $0.71 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Microsoft MSFT | $88.37 B | 1,649.03% | ๐บ๐ธ USA |
Intuit INTU | $6.50 B | 28.72% | ๐บ๐ธ USA |
Splunk SPLK | $3.26 B | -35.45% | ๐บ๐ธ USA |
Neurocrine Biosciences
NBIX | $0.42 B | -91.52% | ๐บ๐ธ USA |